RxSight Corp (RXST): Utang-utang marang kapitalisasi buku

Tandha merek RxSight Inc (RXST)

RxSight, Inc. (RXST) develops specialized lenses for vision correction. This chart reflects the current share price on GURU.Markets at 0.04. Revenue is driven by the automated production of optics and high-margin consumables, despite R&D expenditures. Meanwhile, the company is demonstrating intensive internal growth, deliberately eschewing mergers and independently expanding the distribution network for its innovative products.

RXST - Utang-utang marang aset resik RxSight Ophthalmic ing rentang 04.07.2022 - 27.10.2026
Produk asli RxSight Inc

Explosive demand for LAL light-adjustable lenses is rapidly driving revenue growth for RxSight, Inc. (RXST), creating high market business value. This debt-to-equity ratio measures the proportion of borrowed funds relative to equity, allowing investors to assess the company's financial autonomy and the risk of over-leverage amid current aggressive growth.

Pesaing RxSight, Inc.

BSX: Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku edwards.com EW|RMD: Utang-utang marang kapitalisasi buku|PODD - Utang marang nilai buku|Zimmer Biomet - Utang-utang marang kapitalisasi buku|CooperSurgical (COO) - Utang-utang marang aset resik|ALGN (Align Technology, Inc.) - Utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku GMED|Rasio utang marang kapitalisasi buku TransMedics Organ Care System (TMDX)|Rasio utang marang kapitalisasi buku Alphatec Holdings (ATEC)|Utang-utang marang kapitalisasi buku AORT|ENOV - Utang-utang marang aset resik|Utang marang nilai buku Integra LifeSciences|ESTA - Rasio utang-utang marang kapitalisasi buku|Utang-utang marang kapitalisasi buku BBNX|IRADIMED Corp (IRMD) - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku Embecta Inc. (EMBC)|Rasio utang marang nilai buku Tandem Corp (TNDM)|AxoGen, Inc. (AXGN) - Utang marang nilai buku|Rasio utang marang aset resik SIBN (si-bone.com)|Orthofix - Rasio utang marang kapitalisasi buku|Utang marang nilai buku Bioventus Inc BVS|KIDS (OrthoPediatrics Inc.) - Utang-utang marang kapitalisasi buku|TMCI - Utang-utang marang nilai buku|Utang-utang marang kapitalisasi buku Strata Critical Medical Inc|carlsmed.com (CARL) - Rasio utang marang nilai buku|CLPT: Utang-utang marang kapitalisasi buku|Utang-utang marang aset resik Stereotaxis Inc|Utang-utang marang kapitalisasi buku STIM (NeuroStar)|Utang marang nilai buku Sight Sciences Inc (SGHT)|Utang-utang marang kapitalisasi buku OBIO (Orchestra BioMed, Inc.)|Anika Therapeutics Inc. - Utang-utang marang kapitalisasi buku|NSPR - Rasio utang marang kapitalisasi buku|Jin Medical International (ZJYL) - Rasio utang marang kapitalisasi buku|Utang marang nilai buku vivani.com VANI|Xtant Medical (XTNT) - Rasio utang marang aset resik|Utang-utang marang kapitalisasi buku NMTC (NeuroOne Medical Technologies)|Utang-utang marang nilai buku MODD|MYO: Rasio utang marang kapitalisasi buku|Utang marang aset resik Envoy Medical Inc. COCH|Utang marang nilai buku VVOS (Vivos Therapeutics, Inc)|Utang-utang marang kapitalisasi buku enVVeno Corp NVNO|Utang-utang marang kapitalisasi buku SINT (SINTX Technologies)|TNON: Utang-utang marang aset resik|Rasio utang marang kapitalisasi buku Lifeward (LFWD)|AMIX (Autonomix Medical) - Rasio utang-utang marang kapitalisasi buku|Rasio utang marang kapitalisasi buku IVF|Utang marang nilai buku Bone Biologics Inc|Axonics, Inc. - Utang-utang marang kapitalisasi buku|Utang-utang marang nilai buku BIOL (biolase.com)|DYNT - Rasio utang marang kapitalisasi buku|FNA - Rasio utang marang nilai buku|Utang marang nilai buku INVO Bio INVO